ALLIANCE A091903

Primary Category:

Treatment Protocols

Disease Category:

Melanoma, Metastatic Melanoma, Skin

Status:

Temporarily Closed

A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma

A091903 is temporarily closed to accrual, effective October 10, 2023.

NCT#05111574